The neuroscience company which develops and markets near patient technologies for the assessment of brain health has reported H1Jun16 results showing 11.3% revenue growth to £3.26m and a 46.4% reduction in pretax loss to £0.15m. The evolution of the product portfolio over the last two years is now starting to filter through to increased sales and we believe that the company has the potential to become the market leader in cognitive assessment, with products suitable for every stag
23 Sep 2016
Financials improving. Product capabilities and offering overhaul now complete
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Financials improving. Product capabilities and offering overhaul now complete
Cambridge Cognition Holdings Plc (COG:LON) | 54.5 -0.5 (-1.8%) | Mkt Cap: 19.1m
- Published:
23 Sep 2016 -
Author:
Derren Nathan -
Pages:
6
The neuroscience company which develops and markets near patient technologies for the assessment of brain health has reported H1Jun16 results showing 11.3% revenue growth to £3.26m and a 46.4% reduction in pretax loss to £0.15m. The evolution of the product portfolio over the last two years is now starting to filter through to increased sales and we believe that the company has the potential to become the market leader in cognitive assessment, with products suitable for every stag